In order to ensure that profiled companies receive only qualified email enquiries, Pharmalicensing has upgraded its email enquiry system so that users must be registered and logged in to send email.
This ensures that profiled companies only receive email from qualified registered users of the Pharmalicensing service. Any registered user found to be using the email enquiry service to send unsolicited email will be deleted as a registered user with immediate effect.
If you prefer not to register with Pharmalicensing, but wish to make contact with the profiled company, please use the telephone or mail address provided.
Clients in focus...